Altered expression of glycan genes in cancers induced by epigenetic silencing and tumor hypoxia: Clues in the ongoing search for new tumor markers
( Cancer Sci 2010; 101: 586–593) The glycan molecules that preferentially appear in cancers are clinically utilized as serum tumor markers. The exact reason, however, why glycans are useful as tumor markers remain elusive. Here, we will summarize lessons learned from well‐established cancer‐associat...
Guardado en:
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Revisão |
| Lenguaje: | inglés |
| Publicado: |
2009
|
| Acceso en línea: | https://doi.org/10.1111/j.1349-7006.2009.01455.x https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1349-7006.2009.01455.x |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|